Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Stroke, Ischemic, Thrombectomy, Thrombolytic Therapy, Brain Ischemia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
TARGET-ASPECT (Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke)
Overview
This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.
Primary outcome measures
- Favorable functional outcome defined as a mRS score of 0 to 2 at 90 days [Time frame: 90 days]
Eligibility criteria
Inclusion criteria
- Patients aged 18 years or older
- Confirmed acute ischemic stroke on imaging
- Treated with both thrombolysis and thrombectomy
- Clinical follow-up data available at 90 days (mRS score)
Exclusion criteria
- Primary hemorrhagic stroke
- Early death or loss to follow-up without evaluation
- Poor-quality imaging that cannot be analyzed
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Centre Hospitalier de Gonesse — Gonesse
Identifiers
NCT: NCT07069452 · 0111_NEUROLOGIE